Selected article for: "epidemic epidemic and final size"

Author: Joshua S Weitz; Stephen J Beckett; Ashley R Coenen; David Demory; Marian Dominguez-Mirazo; Jonathan Dushoff; Chung-Yin Leung; Guanlin Li; Andreea Magalie; Sang Woo Park; Rogelio Rodriguez-Gonzalez; Shashwat Shivam; Conan Zhao
Title: Intervention Serology and Interaction Substitution: Modeling the Role of 'Shield Immunity' in Reducing COVID-19 Epidemic Spread
  • Document date: 2020_4_3
  • ID: drj3al9t_7
    Snippet: such that when α = 0 we recover the conventional SIR model. Note that the denominator of 1 + αR can be thought of as S + I + R + αR. Given that S + I + R = 1, this is equivalent to the term 1 + αR. Detailed mixing and substitution models could lead to variations of this model, e.g., in spatially explicit domains, on networks, etc [19] [20] [21] [22] . Figure 2 illustrates shield immunity impacts on an SIR epidemic with R 0 = 2.5. In this SIR .....
    Document: such that when α = 0 we recover the conventional SIR model. Note that the denominator of 1 + αR can be thought of as S + I + R + αR. Given that S + I + R = 1, this is equivalent to the term 1 + αR. Detailed mixing and substitution models could lead to variations of this model, e.g., in spatially explicit domains, on networks, etc [19] [20] [21] [22] . Figure 2 illustrates shield immunity impacts on an SIR epidemic with R 0 = 2.5. In this SIR model, shield immunity reduces the epidemic peak and reduces epidemic duration. In effect, shielding acts as a negative feedback loop, i.e., given that the effective reproduction number is R ef f (t)/R 0 = S(t)/(1 + αR(t)). As a result, interaction substitution increases as recovered individuals increase in number and are identified. For example, in the case of α = 20, the epidemic concludes with less than 20% infected in contrast to the final size of approximately 90% in the baseline scenario without shielding.

    Search related documents:
    Co phrase search for related documents
    • baseline scenario and epidemic peak: 1, 2, 3, 4
    • baseline scenario and final size: 1, 2
    • baseline scenario and immunity impact: 1
    • effective reproduction number and epidemic duration: 1, 2
    • effective reproduction number and epidemic peak: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • effective reproduction number and feedback loop: 1
    • effective reproduction number and final size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • effective reproduction number and immunity impact: 1
    • effective reproduction number and model variation: 1, 2, 3, 4, 5, 6, 7, 8
    • epidemic duration and final size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • epidemic duration and model variation: 1, 2
    • epidemic peak and etc network: 1
    • epidemic peak and final size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epidemic peak and immunity impact: 1
    • epidemic peak and model variation: 1
    • epidemic peak reduce and final size: 1, 2
    • final size and immunity impact: 1
    • final size and model variation: 1
    • immunity impact and interaction substitution: 1, 2